For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Acurx Pharmaceuticals Inc (NASDAQ: ACXP) closed at $0.63 in the last session, up 4.32% from day before closing price of $0.6. In other words, the price has increased by $4.32% from its previous closing price. On the day, 1.57 million shares were traded. ACXP stock price reached its highest trading level at $0.6285 during the session, while it also had its lowest trading level at $0.5511.
Ratios:
We take a closer look at ACXP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.93 and its Current Ratio is at 1.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Scodari Joseph C bought 24,631 shares for $1.01 per share. The transaction valued at 25,000 led to the insider holds 27,708 shares of the business.
Sailer Carl bought 24,631 shares of ACXP for $25,000 on Jan 06 ’25. The Director now owns 137,183 shares after completing the transaction at $1.01 per share. On Jan 06 ’25, another insider, LUCI DAVID P, who serves as the President and CEO of the company, bought 49,261 shares for $1.01 each. As a result, the insider paid 50,000 and bolstered with 1,097,458 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACXP now has a Market Capitalization of 14758185 and an Enterprise Value of 10114302.
Stock Price History:
The Beta on a monthly basis for ACXP is -1.31, which has changed by -0.71919644 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, ACXP has reached a high of $3.33, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is 54.82%, while the 200-Day Moving Average is calculated to be -35.65%.
Shares Statistics:
According to the various share statistics, ACXP traded on average about 5.92M shares per day over the past 3-months and 36516440 shares per day over the past 10 days. A total of 22.40M shares are outstanding, with a floating share count of 20.39M. Insiders hold about 13.17% of the company’s shares, while institutions hold 14.90% stake in the company. Shares short for ACXP as of 1748563200 were 295486 with a Short Ratio of 0.05, compared to 1745971200 on 353013. Therefore, it implies a Short% of Shares Outstanding of 295486 and a Short% of Float of 1.4199998999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of Acurx Pharmaceuticals Inc (ACXP) is the result of assessments by 2.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.11 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.45 and -$0.45 for the fiscal current year, implying an average EPS of -$0.45. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.39 and -$0.55.
